# Temporary MCS With the iVAC 2L Transaortic Device in High-risk PCI

Study · id `cardio:ct-nct07149714` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07149714](<https://clinicaltrials.gov/study/NCT07149714>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07149714

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.

## Technical summary

Registry record NCT07149714. Allocation not applicable; no masking; primary purpose treatment. Start 2023-02-17 (actual); primary completion 2028-02-17 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT07149714, source copy `cardio:ctgov-nct07149714-2025-09-08`, retrieved 2026-10-26)
- Started: 2023-02-17 (actual) (ClinicalTrials.gov record NCT07149714, source copy `cardio:ctgov-nct07149714-2025-09-08`, retrieved 2026-10-26)
- Primary completion: 2028-02-17 (anticipated) (ClinicalTrials.gov record NCT07149714, source copy `cardio:ctgov-nct07149714-2025-09-08`, retrieved 2026-10-26)
- Completion: 2029-02-17 (anticipated) (ClinicalTrials.gov record NCT07149714, source copy `cardio:ctgov-nct07149714-2025-09-08`, retrieved 2026-10-26)
- Countries: Russia (ClinicalTrials.gov record NCT07149714, source copy `cardio:ctgov-nct07149714-2025-09-08`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07149714-2025-09-08`, retrieved 2026-10-26)

## The registry's words

- Brief title: Temporary MCS With the iVAC 2L Transaortic Device in High-risk PCI
- Acronym: POTOK
- Condition: Ischemic Cardiovascular Disease
- Condition: Multivessel Coronary Artery Disease
- Condition: Coronary Artery Disease
- Condition: Cardiogenic Shock
- Condition: Acute Heart Failure (AHF)
- Condition: Chronic Heart Failure
- Condition: Percutaneous Coronary Intervention
- Intervention (Device): iVAC 2L
- Lead sponsor: National Medical Research Center for Cardiology, Ministry of Health of Russian Federation
- Lead sponsor class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Cardiogenic shock (`cardio:cardiogenic-shock`)
- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: National Medical Research Center for Cardiology, Ministry of Health of Russian Federation (`cardio:org-national-medical-research-center-for-cardiology-ministry-of-62fee0`)

## Provenance

Content hash: c0d3dcbe2ceff99c5a0f04641d22edc9f103353ae83e28e8fc3acb18d9375632
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
